Simvastatin prevents the inflammatory process and the dopaminergic degeneration induced by the intranigral injection of lipopolysaccharide
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Anti‐inflammatory strategies have attracted much interest for their potential to prevent further deterioration of Parkinson’s disease. Recent experimental and clinical evidence indicate that statins – extensively used in medical practice as effective lipid‐lowering agents – have also anti‐inflammatory effects. In this study, we investigated the influence of simvastatin on the degenerative process of the dopaminergic neurons of the rat following intranigral injection of lipopolysaccharide (LPS), a potent inductor of inflammation that we have previously used as an animal model of Parkinson’s disease. We evaluated TH positive neurons, astroglial, and microglial populations and found that simvastatin prevented the inflammatory processes, as the induction of interleukin‐1β, tumor necrosis factor‐α, and iNOS and the consequent dopaminergic degeneration induced by LPS. Moreover, simvastatin produced the activation of the neurotrophic factor BDNF, along with the prevention of the oxidative damage to proteins. Moreover, it also prevents the main changes produced by LPS on different mitogen‐activated protein kinases, featured as increases of P‐c‐Jun N‐terminal protein kinase, P‐extracellular signal‐regulated kinase, p‐38, and P‐glycogen synthase kinase and the decrease of the promotion of cell survival signals such as cAMP response element‐binding protein and Akt. Our results suggest that statins could delay the progression of dopaminergic degeneration in disorders involving inflammatory processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Wyss-Coray (2006) · doi:10.1038/nm1484 · Cited by 1,284
Ten years of protein kinase B signalling: a hard Akt to follow
Brazil, D. P., & Hemmings, B. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01958-2 · Cited by 1,177
Mogi, M., Harada, M., Kondo, T., Riederer, P., Inagaki, H., Minami, M., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90508-8 · Cited by 855
Shen, H.-M., & Liu, Z.-G. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.10.056 · Cited by 629
Role of cytokines in inflammatory process in Parkinson’s disease
Sawada, M., Imamura, K., & Nagatsu, T. (2006) · Parkinson’s Disease and Related Disorders · doi:10.1007/978-3-211-45295-0_57 · Cited by 331 · cited 2×
“…under certain pathological conditions through the induction of NADPH-oxidase and high levels of radical oxygen species (ROS) (Koh et al. 1995; Samdani et al. 1997; Kim et al. 2002); the other suggests that neurotrophins may be neuroprotective when no ROS production takes place (Sawada et al. 2006).”
BackgroundThe role of glial cells in Parkinsonʼs disease
Vila, M., Jackson-Lewis, V., Guégan, C., Chu Wu, D., Teismann, P., Choi, D.-K., Tieu, K., & Przedborski, S. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00009 · Cited by 326
Iravani, M. M., Kashefi, K., Mander, P., Rose, S., & Jenner, P. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00562-0 · Cited by 247 · cited 2×
“…glia of tumor necrosis factor-a (TNF-a), interleukin-1b (IL-1b), nitric oxide (NO) and reactive oxygen intermediates among others (Lee et al. 1993; Chao et al. 1995; Jeohn et al. 1998; Kim et al. 2000; Liu et al. 2000; Gao et al. 2002; Gayle et al. 2002; Iravani et al. 2002; Arimoto and Bing 2003).”
BackgroundMechanisms of Statin-mediated Inhibition of Small G-protein Function
Cordle, A., Koenigsknecht-Talboo, J., Wilkinson, B., Limpert, A., & Landreth, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505268200 · Cited by 235 · cited 2×
“…recent studies have shown that statins suppress several kinds of microglial functions, including cell shape determination, cytoskeletal organization, phagocytosis and production of proinflammatory cytokines (Townsend et al. 2004; Cordle and Landreth 2005; Cordle et al. 2005; Kuipers et al. 2006).”
BackgroundStress increases vulnerability to inflammation in the rat prefrontal cortex
de Pablos, R. M., Villarán, R. F., Argüelles, S., Herrera, A. J., Venero, J. L., Ayala, A., Cano, J., & Machado, A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0802-06.2006 · Cited by 215
Self-citation
Cited by
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Fu, S.-P., Wang, J.-F., Xue, W.-J., Liu, H.-M., Liu, B.-R., Zeng, Y.-L., Li, S.-N., Huang, B.-X., Lv, Q.-K., Wang, W., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0230-3 · Cited by 270
The ongoing pursuit of neuroprotective therapies in Parkinson disease
Athauda, D., & Foltynie, T. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.226 · Cited by 269
Statins: Mechanisms of neuroprotection
van der Most, P. J., Dolga, A. M., Nijholt, I. M., Luiten, P. G. M., & Eisel, U. L. M. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.02.002 · Cited by 268
“tatin reduces neurodegeneration in the substantia nigra after injection of lipopolysaccharide (Hernandez-Romero et al., 2008).”
InfluentialDoyle, H. H., Eidson, L. N., Sinkiewicz, D. M., & Murphy, A. Z. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2906-16.2017 · Cited by 166
Metadata
- Authors
- Hernández‐Romero, M. D. C., Argüelles, S., Villarán, R. F., De Pablos, R. M., Delgado‐Cortés, M. J., Santiago, M., Herrera, A. J., Cano, J., & Machado, A.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2007-11-29
- Volume
- 105
- Issue
- 2
- Pages
- 445-459
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2054817857
- Cited by
- 91
- References
- 11
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Simvastatin prevents the inflammatory process and the dopaminergic degeneration induced by the intranigral injection of lipopolysaccharide. https://app.cochat.ai/papers/10.1111/j.1471-4159.2007.05148.x
- The paper
- Hernández‐Romero, M. D. C., Argüelles, S., Villarán, R. F., De Pablos, R. M., Delgado‐Cortés, M. J., Santiago, M., Herrera, A. J., Cano, J., & Machado, A. (2008). Simvastatin prevents the inflammatory process and the dopaminergic degeneration induced by the intranigral injection of lipopolysaccharide. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2007.05148.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.